Clinical outcomes of image-guided percutaneous drainage of pericardial effusion in cancer patients: A single-center retrospective analysis
Authors:
- Tetsuya HasegawaTHTetsuya Hasegawa
- Yasuaki AraiYAYasuaki Arai
- Miyuki SoneMSMiyuki Sone
- Shunsuke SugawaraSSShunsuke Sugawara
- Chihiro ItouCIChihiro Itou
- Shinji WadaSWShinji Wada
- Noriyuki UmakoshiNUNoriyuki Umakoshi
- Takatoshi KuboTKTakatoshi Kubo
- Shintaro KimuraSKShintaro Kimura
- Masahiko KusumotoMKMasahiko Kusumoto
- 1 February 2023
- journal article
- research article
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 19 (1) , 257-262
Abstract
Aim Catheter removal, survival, and recurrence rates after percutaneous pericardial effusion drainage in cancer patients are not fully understood. We evaluated the clinical outcomes of image-guided percutaneous pericardial effusion drainage in cancer patients. Methods From January 2014 to September 2017, 113 percutaneous drainages for symptomatic pericardial effusion were performed in 100 cancer patients (median 60 years; range, 7-84 years) using ultrasound or angio-computed tomography. An 8-Fr drainage catheter was placed using the Seldinger technique via the subxiphoid (n = 73), apical (n = 23), or left parasternal (n = 17) routes. Success rates, complications, and postprocedural clinical outcomes of drainages were retrospectively assessed. Results The technical and clinical success rates were 100% and 99%, respectively, without major complications. The median duration of catheterization and evacuated pericardial effusion volume were 6 days (range, 1-72 days) and 970 ml (range, 140-7635 ml), respectively. Catheters were removed after the first drainage in 86 cases (86%). Symptomatic pericardial effusion recurred in nine patients after catheter removal, in whom redrainages were performed 13 times with a median duration to redrainage time of 48 days (range, 13-529 days). During the follow-up period (median 106 days [range, 1-1396 days]), 61 patients died. The median survival was 140 days (95% confidence interval [CI], 95-276 days), and the median catheter-free survival was 111 days (95% CI, 60-152 days). Conclusions Image-guided percutaneous pericardial effusion drainage for cancer patients is safe and helps alleviate symptoms. Additionally, catheter removal is possible in most patients, allowing a catheter-free period for patients.Keywords
This publication has 22 references indexed in Scilit:
- CT-guided pericardiocenteses: Clinical profile, practice patterns and clinical outcomeEuropean Journal of Radiology, 2010
- Prognosis of Large, Symptomatic Pericardial Effusion Treated by Echo‐guided Percutaneous PericardiocentesisClinical Cardiology, 2008
- Cardiac Tamponade in Medical Patients: A 10-Year Follow-Up SurveyCardiology, 2008
- Abnormal Cytology Predicts Poor Prognosis in Cancer Patients With Pericardial EffusionJournal of Clinical Oncology, 2005
- Consecutive 1127 Therapeutic Echocardiographically Guided Pericardiocenteses: Clinical Profile, Practice Patterns, and Outcomes Spanning 21 YearsMayo Clinic Proceedings, 2002
- Management of pericardial effusion by drainage: a survey of 10 years' experience in a city centre general hospital serving a multiracial population2000
- Echocardiography-guided pericardiocentesis with a needle attached to a probeThe Annals of Thoracic Surgery, 1996
- Two-dimensional echocardiographically guided pericardiocentesis: Experience in 117 consecutive patientsThe American Journal of Cardiology, 1985
- The risk of pericardiocentesisThe American Journal of Cardiology, 1979
- Sensitivity and Specificity of Echocardiographic Diagnosis of Pericardial EffusionCirculation, 1974